Podcast appearances and mentions of Anthony P Bossis

In this encore presentation of an interview with my friend and colleague, Dr. Anthony P. Bossis, we discuss his research into the FDA-approved use of psilocybin – a psychedelic medicine for alleviating anxiety and depression in patients who are seriously or terminally ill.    Most of us don't do a good enough job of talking about serious illness and mortality, and our tendency to shy away from these topics winds up increasing the isolation, anxiety, and depression that seriously ill and dying friends and family too often experience. In this interview, Dr. Bossis sheds light on how the careful use of psilocybin can help improve this part of the life journey for patients, and by extension, those who love them.   Dr. Bossis is a skilled clinician and researcher and a compelling speaker. You can watch his TED Talk about his research here: https://tedxmarin.org/anthony-bossis/   To view the “Curious Explorers” podcast episode on “Psychedelics, Psychic Abilities, & Spiritual Transformation” (with guest Sean McNamara) referred to in the introduction, visit: https://youtu.be/1CiRkzUrvxk?feature=shared   And for more information on Traci Stein, visit: https://www.drtracistein.com/  

We live in an exciting time for psychedelic research. While mental health is often the focus of these medicines, what about their use at the end of life? Our guest, Anthony (Tony) Bossis focuses specifically on those nearing end of life or in palliative care.Tony is clearly passionate about what he does as we delve into cutting-edge research being conducted on the use of high-dose psilocybin for inducing peak experiences and its potential in end-of-life care. He explores the role of psychedelics in fighting demoralization and the fear of death, how we can expand the reach of psychedelic therapies, and the current political state of psychedelic research. His interests and experience make this a captivating and thought-provoking listen for all.“It's always funny to be a scientist talking about love all the time, but I'm glad I am.”Anthony P. Bossis, Ph.D., is a clinical psychologist and clinical assistant professor of psychiatry at NYU School of Medicine, an adjunct professor of classics and religious studies at the University of Ottawa, and an investigator at The Lundquist Institute for Biomedical Innovation. Since 2006, he has been conducting FDA-approved clinical research with the psychedelic compound psilocybin. Dr. Bossis was director of palliative care research and co-principal investigator on the 2016 clinical trial demonstrating a significant reduction in emotional distress from a single psilocybin session in persons with cancer or near the end of life, specifically, a rapid decrease in depression, anxiety, hopelessness, and demoralization along with improvements in spiritual well-being and quality of life. He is the study director and lead therapist on an FDA-approved clinical trial investigating a psilocybin-generated mystical experience with religious leaders.Dr. Bossis is a training supervisor of psychotherapy at NYU-Bellevue Hospital and the co-founder and former co-director of the Bellevue Palliative Care Service. He is on the faculty of The Center for Psychedelic Therapies and Research at the California Institute of Integral Studies and has a long-standing interest in comparative religion, mystical experience, and the interface of psychology and spirituality. His primary psychedelic research interests are the treatment of end-of-life existential distress and advancing our understanding of consciousness, meaning, and spirituality. Dr. Bossis is on the editorial board of the Journal of Humanistic Psychology and a guest editor (with Charles Grob, M.D.) for the journal's Special Series on Psychedelics. He maintains a private psychotherapy and consulting practice in NYC.Show notes:* High dose psilocybin studies* Having a peak experience* The use of psychedelics with end of life* Fighting demoralization* A scientist speaking about love* Can we escape fear of death?* Work with near death experiences* The risks of psychedelic use* Research with psychedelics and Alzheimer's* How to expand psychedelic therapy* How Tony got into this work* The present political state of psychedelic research* This is a remarkable time in the worldLinks and references:* Psychedelic Wisdom* Psychedelic MedicineWant the episode transcript and video? Join our Tribe!Mind Body Health & Politics is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. https://www.mindbodyhealthpolitics.org/subscribe Get full access to Mind Body Health & Politics at www.mindbodyhealthpolitics.org/subscribe

This episode is brought to you by Athletic Greens and Rupa Health.Psychedelics have gotten a bad rap. Often associated with the small period of time they became popular in the 1960s, they were researched in clinical, cultural, and spiritual contexts for many decades prior to that. Now we are seeing an uptick in the interest of drugs like this, which include compounds like psilocybin from certain species of mushrooms, for therapeutic uses. Trials are finding amazing effects on anxiety, depression, PTSD, and fear of death by using psychedelics in a responsible and highly controlled environment. In today's episode, I talk with Dr. Anthony Bossis, Michael Pollan, and Rameshwar Das about the neurobiology of psychedelics, how they can help to shift mindset, and the story of Ram Dass. Anthony P. Bossis, PhD, conducts FDA-approved clinical trials in the reemerging field of psychedelic research. He is a clinical psychologist and clinical assistant professor of psychiatry at NYU School of Medicine, where he investigates the effects of psilocybin, a naturally occurring compound found in specific species of mushrooms. Michael Pollan is the author of the New York Times bestsellers Cooked, Food Rules, In Defense of Food, The Omnivore's Dilemma, The Botany of Desire, How to Change Your Mind, and This Is Your Mind on Plants. Rameshwar Das has been navigating a spiritual path for 50 years. Ramesh met Ram Dass in 1968 and spent time with Neem Karoli Baba in India from 1970–72. He learned Vipassana meditation from Goenka in India. Ramesh has worked as an artist, photographer, environmentalist, and writer. He has collaborated on many projects with Ram Dass over the years, including the original Be Here Now and the Love Serve Remember recordings, and he has coauthored three books with Ram Dass: Be Love Now, Polishing the Mirror, and Being Ram Dass. This episode is brought to you by Athletic Greens and Rupa Health.AG1 contains 75 high-quality vitamins, minerals, whole-food sourced superfoods, probiotics, and adaptogens to support your entire body. Right now when you purchase AG1 from Athletic Greens, you will receive 10 FREE travel packs with your first purchase by visiting athleticgreens.com/hyman.Rupa Health is a place where Functional Medicine practitioners can access more than 2,000 specialty lab tests from over 20 labs like DUTCH, Vibrant America, Genova, and Great Plains. You can check out a free, live demo with a Q&A or create an account at RupaHealth.com.Full-length episodes of these interviews can be found here:Dr. Anthony BossisMichael PollanRameshwar Das See acast.com/privacy for privacy and opt-out information.

Episode 43 - Dr. Tony Bossis  Meeting the End of Life with Psychedelics In this all new episode of the MAPS Podcast, Zach Leary sits down with NYU's Dr. Tony Bossis to talk about a single dose of psilocybin can provide an entirely new perspective in dealing with death and dying. Dr. Bossis shares so much wisdom, knowledge and unique understanding on his work and the future of psychedelic research.  Anthony P. Bossis, PhD, is a clinical psychologist and clinical assistant professor of psychiatry at NYU School of Medicine conducting FDA-approved research with the psychedelic compound psilocybin since 2009. Dr. Bossis was director of palliative care research and co-principal investigator on a clinical trial demonstrating a reduction in emotional distress from a single psilocybin session in persons with cancer and is study director on a clinical trial evaluating psilocybin-generated mystical experience upon religious leaders. Dr. Bossis is a training supervisor of psychotherapy at NYU-Bellevue Hospital Center and co-founder and former co-director of the Bellevue Hospital Palliative Care Service. He has a long-standing interest in comparative religion, mystical experience and the interface of psychology and spirituality. He maintains a private psychotherapy and consulting practice in NYC.

The Reemerging Field of Psychedelic Research | This episode is brought to you by Perfect KetoHallucinogens like lysergic acid diethylamide (LSD) and psilocybin (a compound derived from certain species of mushrooms) were being researched in medicine as therapeutic agents before their recreational popularity boomed in the 1960s. Unfortunately, that era gave them a negative connotation and since then the research in medical psychedelics dramatically declined. Now, we are seeing a resurgence in interest for these types of therapies, and the research points to some positive benefits.One of the most astounding things about using various compounds, like psilocybin, as medicine is the long-lasting and powerful benefits of a single dose. Dr. Hyman sits down for a conversation with Dr. Anthony Bossis, where he shares about his experience conducting psychedelic research.Anthony P. Bossis, Ph.D. conducts FDA-approved clinical trials in the reemerging field of psychedelic research. He is a clinical psychologist and clinical assistant professor of psychiatry at NYU School of Medicine investigating the effects of psilocybin, a naturally occurring compound found in specific species of mushrooms. Dr. Bossis was director of palliative care research, co-principal investigator, co-author, and session guide on the 2016 landmark study showing a significant reduction in emotional distress along with enhanced existential well being from a single psilocybin-generated mystical experience in persons with cancer.Dr. Bossis is a supervisor of psychotherapy at Bellevue Hospital and co-founder and former co-director of the Bellevue Hospital Palliative Care Service and maintains a private psychotherapy practice in NYC.This episode is brought to you by Perfect Keto. Right now, Perfect Keto is offering Doctor’s Farmacy listeners 20% off plus free shipping with the code DRMARK. Just go to perfectketo.com/drmark, and make sure you try their Nut Butters and Keto Cookies.Find Dr. Hyman’s full-length conversation with Dr. Anthony Bossis, “Are Psychedelics the New Wonder Drug for Mental Illness and the Fear of Death?” here: https://DrMarkHyman.lnk.to/AnthonyBossis See acast.com/privacy for privacy and opt-out information.

Clinical psychologist Anthony P. Bossis joins Raghu on the Mindrolling Podcast for a conversation about his research on psychedelics and learning to put trust in consciousness through the psychedelic experience.Anthony P. Bossis, PhD, is a clinical psychologist and clinical assistant professor of psychiatry at NYU School of Medicine. He conducts FDA approved psychedelic research investigating the therapeutic efficacy of psilocybin on existential and psycho-spiritual distress at the end of life. Anthony is a co-founder of Palliative Care Service at Bellevue Hospital and on the advisory committee and faculty for the Art of Dying Institute in New York City where he maintains a private psychotherapy practice.

Anthony P. Bossis, Ph.D. a clinical psychologist and clinical assistant professor of psychiatry at NYU School of Medicine. Anthony is conducting FDA-approved psychedelic research investigating the effects of psilocybin, a natural compound found in specific species of mushrooms. Implications for the study of psilocybin / mystical experience include the alleviation of end-of-life distress, enhanced psychological well-being, treatment of myriad mental health disorders, and for the study of meaning, spirituality, and consciousness.

Anthony P. Bossis, Ph.D. a clinical psychologist and clinical assistant professor of psychiatry at NYU School of Medicine. Anthony is conducting FDA-approved psychedelic research investigating the effects of psilocybin, a natural compound found in specific species of mushrooms. Implications for the study of psilocybin / mystical experience include the alleviation of end-of-life distress, enhanced psychological well-being, treatment of myriad mental health disorders, and for the study of meaning, spirituality, and consciousness.

When it comes to medicine, many of us want immediate results. What if just one dose of medicine could dramatically shift your perception, decreasing anxiety, depression, fear of death, addictive tendencies, and so much more? It might sound too good to be true, but the therapeutic use of psychedelics is showing us it’s possible.Now, I’m not talking about taking magic mushrooms at a Grateful Dead concert. The medicine used in psychedelic trials is created in a lab, carefully dosed for the patient, and administered in a specific setting with a trained guide who is present throughout the entire process. This highly controlled process can yield some pretty amazing results and we will be seeing much more science emerge on the safe use of psychedelics for a variety of disorders. This week on The Doctor’s Farmacy, Dr. Anthony Bossis joins me to elaborate on using psychedelics to expand our sensory abilities and relax our experience with death and illness. Anthony P. Bossis, Ph.D. conducts FDA-approved clinical trials in the reemerging field of psychedelic research. He is a clinical psychologist and clinical assistant professor of psychiatry at NYU School of Medicine investigating the effects of psilocybin, a naturally occurring compound found in specific species of mushrooms. See acast.com/privacy for privacy and opt-out information.

Anthony P. Bossis, Ph.D. is a clinical psychologist and Clinical Assistant Professor of Psychiatry at New York University School of Medicine, where he and colleagues are conducting government approved clinical research with the hallucinogenic compound psilocybin. He is director of palliative care research, co-principal investigator, and a session guide for a study of the effects of a psilocybin-facilitated mystical experience on cancer patients.  He is also Project Director and session guide for the Religious Leader Psilocybin Study, which evaluates the effects of a psilocybin-facilitated mystical experience on religious leaders.  We spoke about his groundbreaking experiments and his interest in comparative religion, consciousness research, and the interface of psychology and spirituality. Learn more about Dr. Anthony Bossis here: https://www.nyu.edu/about/news-publications/news/2013/01/30/the-potential-of-psilocybin-to-alleviate-psychological-and-spiritual-distress-in-cancer-patients-is-revealed.html

Anthony P. Bossis, Ph.D. is a clinical psychologist and Clinical Assistant Professor of Psychiatry at New York University School of Medicine, where he and colleagues are conducting government approved clinical research with the hallucinogenic compound psilocybin. He is director of palliative care research, co-principal investigator, and a session guide for a study of the effects of a psilocybin-facilitated mystical experience on cancer patients.  He is also Project Director and session guide for the Religious Leader Psilocybin Study, which evaluates the effects of a psilocybin-facilitated mystical experience on religious leaders.  We spoke about his groundbreaking experiments and his interest in comparative religion, consciousness research, and the interface of psychology and spirituality. Learn more about Dr. Anthony Bossis here: https://www.nyu.edu/about/news-publications/news/2013/01/30/the-potential-of-psilocybin-to-alleviate-psychological-and-spiritual-distress-in-cancer-patients-is-revealed.html